SIC 2833 – Medicinal Chemicals and Botanical Products
Valuation | |
---|---|
Market Cap ($M) | n/a |
Enterprise Value ($M) | n/a |
Book Value ($M) | 0.00 |
Book Value / Share | n/a |
Price / Book | n/a |
NCAV ($M) | 0.00 |
NCAV / Share | n/a |
Price / NCAV | n/a |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | n/a |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | n/a |
Current Ratio | n/a |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 0.00 |
Assets | 0.00 |
Liabilities | 0.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -0.00 |
Net Income | -0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Similar Companies | |
---|---|
ABTI – Alterola Biotech, Inc. | ACUR – Acura Pharmaceuticals, Inc. |
ACUT – AccuStem Sciences, Inc. | ADXS – Ayala Pharmaceuticals, Inc. |
AFFY – Affymax, Inc. |
Financial data and stock pages provided by
Fintel.io